Stay Informed: Transforming Radiology with Structured Reporting and Data-Driven Approaches

Dive into our activities, projects, and product updates. Catch on the latest industry news and learn who we are as a company and as a team.

New iRECIST Oncologic Response Criteria already in clinical use at the University Medical Center – Tübingen, Germany

Shortly following the release of the new iRECIST- oncologic response criteria (Lancet Oncology, March 2017) the University Medical Center in Tübingen, Germany had already begun to implement this new response criteria into their clinical routine using mint LesionTM. The iRECIST guidelines are intended to provide a standard approach to the evaluation of solid tumors with measurements and assessment of the disease burden in trials where an immunotherapy is used.

PD Dr. Bernhard Klumpp who provides radiological response evaluation of of studies is one of the first radiologists to apply the new iRECIST response assessment in mint LesionTM. “The possibility of transferring the existing report process to an iRECIST process is of course sensational. For this a new measurement is not necessary, one simply changes perspective during observation of the process. Moreover, special features of iRECIST are indicated in the application”, says Dr. Klumpp.

The new iRECIST response evaluation platform is now available for all mint LesionTM Users. iRECIST is expected to be widely applied in both routine radiology evaluation as well as for application as a standardized response assessment methodology as required in oncology clinical trials.

Related Resources

Related Resources

Screenshot of the Mint Medical Template Designer interface showcasing customizable research templates and logic rule integration for efficient data collection.

Transform Your Research with the Template Designer

At Mint Medical, we know that organized and high-quality data is the foundation of successful research. That's why we've developed the Template…

ESOI-EORTC Workshop: Hands-On Training in Assessing Tumor Response to Treatment

The ESOI-EORTC workshop, hosted by the European Society of Oncological Imaging (ESOI) and the European Organization for Research and Treatment of…

Systems on FHIR: Driving Healthcare Innovation Through Interoperability

Interoperability is revolutionizing healthcare by enabling the seamless exchange of patient data across systems. This efficient data flow is critical…